Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05337306 · ClinicalTrials.gov registry record · NA
Improving Diabetic Patient Health Through Assistive-Reading Technology
A NA study of Diabetes Mellitus, Type 2 and Health Knowledge, Attitudes, Practice, sponsored by GogyUp.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
- 1
- Study location
NCT05337306 is a NA study of Diabetes Mellitus, Type 2 and Health Knowledge, Attitudes, Practice that has completed, run by GogyUp. The registered enrollment target is 193 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05337306, a NA study of Diabetes Mellitus, Type 2 and Health Knowledge, Attitudes, Practice, has completed, sponsored by GogyUp.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
- 1
- Study location
Study Summary
Type 2 Diabetes Mellitus (T2DM) affects over 30 million Americans and requires patients to competently manage their conditions at home. However, the majority of diabetes self-management education (DSME) and aftercare print materials remain overly complicated, with excessively high reading difficulty and fall short in supporting functional readiness for self- management at home, especially for the 18% of U.S. adults unable to read beyond a second-grade level. This project will determine the feasibility of implementing assistive reading technology, designed for patients with limited print or English proficiency, that will immediately expand patient capacity to understand DSME materials, increase T2DM self- management adherence and eventually reduce, at a scale, disparate outcomes in a chronic disease. It will use a small pilot trial design of the GogyUp Reader app to use with print materials versus print materials with no app support and test effects of GogyUp on three-month follow-up measures of health literacy (primary outcome) using the Health Literacy Questionnaire subscales 9 (Understanding health information well enough to know what to do") and 2 ("Having sufficient information to manage my health"); and on three-month follow-up self-reported diabetes management (secondary outcome) using the Perceived Diabetes Self-Management Scale (PDSMS).
Conditions Studied
Interventions
- OTHER GogyUp Reader
Study Locations (1)
Minnesota
- MHealth Fairview system - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05337306
The ClinicalTrials.gov registry entry for NCT05337306 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The listed sponsor is GogyUp, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which GogyUp Reader is the first listed.
NCT05337306 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05337306 about?
NCT05337306 is a clinical study titled "Improving Diabetic Patient Health Through Assistive-Reading Technology". Type 2 Diabetes Mellitus (T2DM) affects over 30 million Americans and requires patients to competently manage their conditions at home. However, the majority of diabetes self-management education (DSME) and aftercare print materials remain overly complicated, with excessively high reading difficulty...
What is the current status of trial NCT05337306?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2023-04-26. Estimated completion is 2024-06-30.
What conditions does trial NCT05337306 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Health Knowledge, Attitudes, Practice, Literacy.
What interventions are being tested in trial NCT05337306?
The interventions under investigation include: GogyUp Reader (OTHER).
Who is sponsoring clinical trial NCT05337306?
This trial is sponsored by GogyUp, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05337306 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Diabetes Mellitus, Type 2
All registered trials for this condition
Health Knowledge, Attitudes, Practice
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.